Page 1 | Search Results | Blood | American Society of Hematology

1-8 of 8

Sort by

Sort Order Select

Journal Articles

North American ATLL has a distinct mutational and transcriptional profile and responds to epigenetic therapies

Blood (2018) 132 (14): 1507–1518.

https://doi.org/10.1182/blood-2018-01-824607

Published: 2018

Includes: Supplemental data

Journal Articles

Mutational Frequency in Hispanic and Non-Hispanic Patients with Acute Myeloid Leukemia (AML): Updated Analysis of 227 Patients

Terrence J Bradley, MD, Jorge Monge, MD, Chetasi Talati, MD, Sandra Dannielle Algaze, MD BS, Christine Angela Vaupel, PhD, Jennifer R Chapman, MD, Francisco Vega, MD PhD, Jeff Hall, Jeffrey E. Lancet, MD, Eric Padron, MD, Ronan T. Swords, MD PhD FRCPI, FRCPath, Justin M Watts, MD

Blood (2017) 130 (Supplement 1): 2699.

https://doi.org/10.1182/blood.V130.Suppl_1.2699.2699

Published: 2017

Journal Articles

Mutational Frequency in Hispanic Vs. Non-Hispanic Patients with Acute Myeloid Leukemia (AML)

Jorge Monge, MD, Christine Vaupel, PhD, Ronan T Swords, MD PhD FRCPI, FRCPath, Terrence Bradley, MD, Ryan Chapman, DO, Naiomi Gunaratne, Jennifer R Chapman, MD, Francisco Vega, MD PhD, Eric Padron, MD, Fernando Vargas, MD, Jeff Hall, PhD, Justin M Watts, MD

Blood (2016) 128 (22): 2796.

https://doi.org/10.1182/blood.V128.22.2796.2796

Published: 2016

Journal Articles

Genetic Sequencing of Adult T-Cell Leukemia/Lymphoma in the Caribbean Population Shows a Distinct Mutational Profile When Compared to the Japanese Cohort

Urvi A Shah, MD, B. Hilda Ye, PhD, Jeff Hall, PhD, Yanhua Wang, MD PhD, Ronald Rice, MD PhD, Rizwan Naeem, MD, Amara Gayathri Nandikolla, MD, Swati Goel, MD, Ioannis Mantzaris, MD, Aditi Shastri, MD, Olga Derman, MD, Noah Kornblum, MD, Ira Braunschweig, MD, Amit Verma, MD, Murali Janakiram, MD

Blood (2016) 128 (22): 1758.

https://doi.org/10.1182/blood.V128.22.1758.1758

Published: 2016

Journal Articles

Clinical Utility of Molecular Profiling in Higher Risk MDS Treated with Azacitidine: Can We Tailor Therapy Accordingly?

David Sallman, MD, Eric Padron, MD, Jinming Song, MD PhD, Mohammad Omar Hussaini, MD, Christine Vaupel, PhD, Najla H Al Ali, Jeffrey E. Lancet, MD, Jeff Hall, PhD, Alan F List, MD, Rami S. Komrokji, MD

Blood (2016) 128 (22): 1984.

https://doi.org/10.1182/blood.V128.22.1984.1984

Published: 2016

Journal Articles

Prognostic Impact of ASXL1 Mutations in MDS and CMML

David Sallman, MD, Eric Padron, MD, Christine Vaupel, PhD, Thomas Cluzeau, MDPhD, Najla H. Al Ali, BDS, MSc, Jeffrey E Lancet, MD, Jeff Hall, PhD, Alan F. List, MD, Rami S. Komrokji, MD

Blood (2015) 126 (23): 1673.

https://doi.org/10.1182/blood.V126.23.1673.1673

Published: 2015

Journal Articles

Prognostic Value of Circulating Myeloblasts in Patients with Myelodysplastic Syndromes (MDS): A Proposal for Incorporation in the Revised International Prognostic Scoring System (R-IPSS)

Rami S Komrokji, MD, Eric Padron, MD, Najla H Al Ali, Jeffrey E Lancet, MD, Jeff Hall, PhD, Brian Kwok, MD, Ling Zhang, MD, Pearlie K Epling-Burnette, PhD, Alan F List, MD

Blood (2014) 124 (21): 4650.

https://doi.org/10.1182/blood.V124.21.4650.4650

Published: 2014

Journal Articles

Somatic Mutations Indicative of Clonal Hematopoiesis Are Present in a Large Fraction of Cytopenic Patients Who Lack Diagnostic Evidence of MDS

Jeff Hall, PhD, Jenan Al Hafidh, PhD, Emily Balmert, Bashar Dabbas, MD, Christine Vaupel, PhD, Carlos El Hader, PhD, Matthew McGinniss, PhD, Sue Beruti, MD, Rafael Bejar, MDPhD

Blood (2014) 124 (21): 3272.

https://doi.org/10.1182/blood.V124.21.3272.3272

Published: 2014

NARROW

North American ATLL has a distinct mutational and transcriptional profile and responds to epigenetic therapies

Mutational Frequency in Hispanic and Non-Hispanic Patients with Acute Myeloid Leukemia (AML): Updated Analysis of 227 Patients

Mutational Frequency in Hispanic Vs. Non-Hispanic Patients with Acute Myeloid Leukemia (AML)

Genetic Sequencing of Adult T-Cell Leukemia/Lymphoma in the Caribbean Population Shows a Distinct Mutational Profile When Compared to the Japanese Cohort

Clinical Utility of Molecular Profiling in Higher Risk MDS Treated with Azacitidine: Can We Tailor Therapy Accordingly?

Prognostic Impact of ASXL1 Mutations in MDS and CMML

Prognostic Value of Circulating Myeloblasts in Patients with Myelodysplastic Syndromes (MDS): A Proposal for Incorporation in the Revised International Prognostic Scoring System (R-IPSS)

Somatic Mutations Indicative of Clonal Hematopoiesis Are Present in a Large Fraction of Cytopenic Patients Who Lack Diagnostic Evidence of MDS

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only